Cameco's strong uranium output, rising revenues and steady contracts make it stand out over Uranium Energy's volatile results.
The next wave of upside for the technology sector is now found in the future of data centers, since the United States is absolutely focused on onshoring the artificial intelligence capacity and footprint in the coming years.
CCJ posts Q2 revenue growth of 47% and EPS rise of 410%, fueled by uranium volume gains and strong Westinghouse earnings.
Zacks.com users have recently been watching Cameco (CCJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CCJ's Q2 net earnings soar 792% on Westinghouse gains, fueling a strong outlook and 45.2% year-to-date stock surge.
President Trump's executive order boosts U.S. nuclear energy, benefiting uranium producers like Cameco Corporation and excluding uranium from new tariffs. Growing demand for nuclear energy and rising geopolitical tensions are driving uranium demand, with projections of a 140% increase by 2050. Cameco is positioned as a leading uranium producer with top-tier assets and global operations, poised to capitalize on industry growth.
Cameco Corporation (NYSE:CCJ ) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET Company Participants Cory Kos - Vice-President of Investor Relations Grant E. Isaac - Executive VP & CFO Heidi Shockey - Senior VP & Deputy CFO Timothy S.
Cameco (CCJ) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.1 per share a year ago.
Buy-and-hold investors frequently buy blue-chip stocks. These are large-cap and mega-cap stocks that have mature business models.
Cameco is set to post sharply higher Q2 revenues and EPS, but an earnings beat may remain out of reach.
Key Points in This Article: The uranium sector is set to grow due to global nuclear capacity expansion and supportive U.S.
Recently, Zacks.com users have been paying close attention to Cameco (CCJ). This makes it worthwhile to examine what the stock has in store.